BioAge Labs, Inc.
Develops therapies for metabolic diseases like obesity by targeting the biology of human aging.
BIOA | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 5885 HOLLIS STREET, 94608 EMERYVILLE
- Website:
- https://bioagelabs.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company dedicated to developing therapies for metabolic diseases by targeting the biology of human aging. The company's core strategy involves a human-first discovery platform that analyzes proprietary multi-omics data to identify molecular pathways associated with metabolic aging. Its therapeutic pipeline is focused on cardiometabolic diseases, particularly obesity. Key programs include BGE-102, an anti-inflammatory drug candidate targeting the NLRP3 pathway to address appetite dysregulation and insulin resistance, and an APJ agonist designed to function as an exercise mimetic to improve body composition and weight loss.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all BioAge Labs, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioAge Labs, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioAge Labs, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
